神经内分泌肿瘤心脏转移:SSTR PET/CT与心脏MRI的互补作用
单中心回顾性研究纳入19例神经内分泌肿瘤(NEN)心脏转移患者,全部行生长抑素受体(SSTR)PET/CT,其中10/19例行心脏MRI(CMR),由影像专科医师盲法复阅并记录转移灶数目与位置。SSTR PET/CT检出的转移灶多于CMR,而CMR对病灶定位更准确;12/19例接受肽受体放射性核素治疗(PRRT),未出现心脏不良事件。
要点
- 19例NEN心脏转移患者中,SSTR PET/CT检出转移灶数目多于CMR。
- CMR所识别的转移灶定位较SSTR PET/CT更准确。
- 12/19例接受PRRT,未发生心脏不良事件。
核心结论
- SSTR PET/CT与CMR是NEN心脏转移成像中的互补检查,SSTR PET/CT对病灶检出似乎更敏感,CMR对病灶定性更好,二者均为包括PRRT在内的治疗计划提供有用信息,PRRT给药安全。
研究设计与样本
- 单中心回顾性研究,共识别19例神经内分泌肿瘤心脏转移患者,全部行SSTR PET/CT,10/19例行CMR。
- 回顾电子病历,对可获得的SSTR PET/CT与CMR由影像专科医师盲法复阅,记录心脏转移灶数目与位置。
主要发现
- SSTR PET/CT检出的转移灶数目多于CMR,而CMR识别出的转移灶定位更准确。
- 12/19例患者接受PRRT,未出现心脏不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac metastases from neuroendocrine neoplasms (NENs) are being detected with increasing frequency, although the optimal imaging strategy remains unclear. We performed a single-center retrospective study to explore the role of somatostatin receptor positron emission tomography/computed tomography (SSTR PET/CT) and cardiac magnetic resonance imaging (CMR) in NEN cardiac metastases, determine the degree of concordance between the findings of these imaging modalities, and examine the advantages and disadvantages of each imaging technique. A secondary aim was to determine if cardiac metastases were associated with adverse cardiac events during peptide receptor radionuclide therapy (PRRT). METHODS AND RESULTS: 19 patients with NEN cardiac metastases were identified. A retrospective review of electronic medical records was performed, and if available SSTR PET/CT and CMR were blindly re-reviewed by imaging specialists, documenting the number and location of cardiac metastases. All 19 patients had SSTR PET/CT, and 10/19 patients had CMR. SSTR PET/CT identified more metastases than CMR. When identified on CMR, metastases were more accurately localized. 12/19 patients received PRRT, with no cardiac adverse effects. CONCLUSION: SSTR PET/CT and CMR are complementary investigations in the imaging of NEN cardiac metastases. SSTR PET/CT appears more sensitive for lesion detection, and CMR offers better lesion characterization. Both investigations present useful information for the planning of treatment including PRRT, which was administered safely.
引用
- Arnfield EG, Tam L, Pattison DA, et al. Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI. J Nucl Cardiol. 2023. PMID: 37587328. doi:10.1007/s12350-023-03345-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。